Christiane S Hampe Selected Research

anti-GAD65 autoantibody

10/2018	GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.
1/2012	Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse.
8/2008	GAD65 autoantibody responses in Japanese latent autoimmune diabetes in adult patients.
2/2002	Stable GAD65 autoantibody epitope patterns in type 1 diabetes children five years after onset.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christiane S Hampe Research Topics

Disease

42	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 02/2002
12	Stiff-Person Syndrome (Stiff Man Syndrome) 10/2018 - 12/2005
9	Cerebellar Ataxia (Dysmetria) 04/2019 - 02/2011
9	Ketosis 01/2019 - 11/2003
7	Type 2 Diabetes Mellitus (MODY) 01/2020 - 11/2004
5	Insulin Resistance 01/2022 - 12/2005
5	Ataxia (Dyssynergia) 01/2019 - 04/2016
5	Autoimmune Diseases (Autoimmune Disease) 06/2015 - 12/2009
5	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 06/2014 - 11/2003
4	Obesity 01/2020 - 09/2015
3	Mucopolysaccharidosis I (Hurler Syndrome) 01/2021 - 01/2020
3	Neoplasms (Cancer) 01/2020 - 01/2017
3	Nervous System Diseases (Neurological Disorders) 10/2018 - 07/2013
3	Psychotic Disorders (Schizoaffective Disorder) 09/2015 - 12/2010
3	Latent Autoimmune Diabetes in Adults 01/2014 - 08/2008
2	Inflammation (Inflammations) 01/2020 - 01/2018
2	Autism Spectrum Disorder 11/2019 - 09/2015
2	Epilepsy (Aura) 10/2018 - 12/2016
2	Paraneoplastic Cerebellar Degeneration 08/2018 - 04/2016
2	Hyperglycemia 01/2018 - 01/2017
2	Cerebellar Diseases (Cerebellar Syndrome) 01/2018 - 06/2013
2	Glucose Intolerance 12/2017 - 12/2008
2	Graves Disease (Basedow Disease) 06/2013 - 02/2010
1	Communicable Diseases (Infectious Diseases) 02/2022
1	Mucopolysaccharidoses 07/2021
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 07/2021
1	Genetic Risk Score 01/2020
1	Fever (Fevers) 01/2020
1	Congenital Abnormalities (Deformity) 01/2020
1	Seizures (Absence Seizure) 11/2019
1	Eclampsia 11/2019
1	Pre-Eclampsia (Preeclampsia) 11/2019
1	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2019
1	Stroke (Strokes) 08/2018
1	Multiple Sclerosis 08/2018
1	Wounds and Injuries (Trauma) 08/2018
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2018
1	Friedreich Ataxia (Friedreich's Ataxia) 01/2018
1	Prediabetic State (Prediabetes) 12/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Dyslipidemias (Dyslipidemia) 01/2017
1	Disease Progression 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Hashimoto's encephalitis 04/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2016
1	Miller Fisher Syndrome (Fisher Syndrome) 04/2016

Drug/Important Bio-Agent (IBA)

43	AutoantibodiesIBA 01/2022 - 02/2002
22	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2022 - 08/2002
21	EpitopesIBA 10/2018 - 02/2002
17	Protein Isoforms (Isoforms)IBA 01/2022 - 08/2002
15	AntibodiesIBA 01/2020 - 01/2003
14	Insulin (Novolin)FDA Link 01/2020 - 06/2008
9	EnzymesIBA 01/2021 - 07/2004
7	AutoantigensIBA 01/2014 - 08/2002
7	glutamate decarboxylase 2IBA 07/2013 - 12/2005
5	Anti-Idiotypic AntibodiesIBA 06/2014 - 04/2008
4	Glutens (Glutelin)IBA 01/2019 - 04/2016
4	anti-GAD65 autoantibodyIBA 10/2018 - 02/2002
3	Proteins (Proteins, Gene)FDA Link 02/2022 - 02/2002
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2017
3	Iduronidase (alpha-L-Iduronidase)IBA 01/2021 - 01/2020
3	Carboxy-LyasesIBA 01/2019 - 02/2007
3	HLA Antigens (Human Leukocyte Antigens)IBA 06/2014 - 11/2003
3	Monoclonal AntibodiesIBA 02/2010 - 11/2003
2	Peptides (Polypeptides)IBA 01/2022 - 01/2020
2	GlycosaminoglycansIBA 07/2021 - 01/2020
2	C-PeptideIBA 01/2020 - 06/2015
2	ProinsulinIBA 01/2020 - 05/2010
2	Dopamine (Intropin)FDA LinkGeneric 11/2019 - 09/2015
2	ProlactinIBA 11/2019 - 09/2015
2	AntigensIBA 01/2019 - 06/2012
2	Thyrotropin Receptors (Thyrotropin Receptor)IBA 06/2013 - 02/2010
2	aluminum sulfate (alum)IBA 05/2012 - 10/2010
2	CytokinesIBA 01/2012 - 12/2010
1	Sulfates (Sulfates, Inorganic)IBA 08/2020
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2020
1	CollagenIBA 01/2020
1	OsteocalcinIBA 01/2020
1	ICA512 autoantibodyIBA 12/2018
1	Tyrosine (L-Tyrosine)FDA Link 12/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2018
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2018
1	OrnithineIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Familial apoceruloplasmin deficiencyIBA 01/2018
1	Arginine (L-Arginine)FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Thyroid HormonesIBA 01/2018
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	Transaminases (Aminotransferases)IBA 01/2017
1	Glutamic Acid (Glutamate)FDA Link 12/2016
1	AcidsIBA 12/2016
1	Surface Antigens (Surface Antigen)IBA 01/2016

Therapy/Procedure

2	Therapeutics 01/2021 - 04/2009
1	Tissue Expansion 01/2020
1	Gluten-Free Diet 01/2019
1	Fecal Microbiota Transplantation 11/2017
1	Immunotherapy 01/2017